FDA Inspection 1293386 — Monika Meglicka, MD, PhD
The FDA completed an inspection of Monika Meglicka, MD, PhD on Nov 7, 2025 in Warsaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warsaw (Poland)
Additional details
Clinical Investigator (CI)